About Us

We’ve rebranded some of our products, learn more ›

CODEX is now PhenoCycler
Phenoptics is now Phenolmager

Explore our history​​

At Akoya, we believe context is key. Our single-cell imaging solutions phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response. The PhenoCycler™ (formerly CODEX®) and PhenoImager™ (formerly Phenoptics™) workflows complement each other to provide a comprehensive solution that serves the diverse needs of researchers across discovery, translational and clinical research.

Today
The Spatial Biology Company®
Akoya Biosciences unveils an innovative, integrated suite of solutions to enable unbiased spatial phenotyping at unprecedented speeds, setting a new standard in spatial biology.
Today
2018
Akoya Biosciences Acquires Phenoptics
Akoya Biosciences acquires the Phenoptics portfolio from PerkinElmer® to establish a combined portfolio of complementary technologies
2018
2015
Akoya Biosciences is Founded
Akoya Biosciences was founded to commercialize the CODEX® technology, developed in the lab of Dr. Garry Nolan at Stanford University, to enable ultrahigh multiplexed analysis for biomarker discovery.
2015
2011
PerkinElmer Acquires Caliper Life Sciences
The Phenoptics™ portfolio, based on MSI technology, becomes the industry standard for multiplexed tissue analysis in translational research.
2011
1985
Cambridge Research & Instrumentation (CRI)
CRI is co-founded by Peter Miller and Cliff Hoyt to commercialize revolutionary Multispectral Imaging (MSI) technology. CRI is acquired by Caliper Life Sciences in 2010 to accelerate MSI development for tissue biomarker analysis
1985